In Vivo 18 F-Florzolotau Tau Positron Emission Tomography Imaging in Parkinson's Disease Dementia.

Yi-Lin TangLing LiTianyu HuFangyang JiaoLinlin HanShiyu LiZhiheng XuYun FanYimin SunFeng-Tao LiuTzu-Chen YenChuan-Tao Zuo Jian Wang

Published in: Movement disorders : official journal of the Movement Disorder Society (2022)

F-Florzolotau PET imaging can effectively capture the occurrence of tau pathology in patients with PDD, which was also linked to MMSE scores. © 2022 International Parkinson and Movement Disorder Society.

Keyphrases

pet imaging
positron emission tomography
computed tomography
cerebrospinal fluid
mild cognitive impairment
high resolution
risk assessment
pet ct
cognitive impairment